Medicare committee recommends expensive drug for some prostate-cancer patients
"A new treatment for prostate cancer called Provenge won a vote of confidence from a Medicare coverage advisory committee Wednesday, suggesting the federal program is likely to pay for the $93,000-per-patient medicine," The Wall Street Journal reports.
Join the discussion below, or Read more at Medical News.
#1 Nov 20, 2010
why do thet say the prce is high ,texterone ..with radiation ,chemo,medical follow ups ,over 200,000....welfare having 5...7...10 kids ..=60,80,100,000. dollars ..nothing said about this the seniors that need dndn ,that paid into the system,40,50,years ,they deny ,ssraises they take away ,is this the great american ,system ..??
Add your comments below
|Dendreon's good news may help these three micro... (Nov '10)||Sep '13||Harrison||3|
|FDA May Approve Revolutionary Cancer Vaccine (Apr '10)||Sep '13||Howard||2|
|Stock Losers: Tenet Healthcare Corp, Dendreon C... (Apr '13)||Apr '13||Beta Jewelry||1|
|Exclusive: Questionable data propped up cancer ... (Oct '12)||Oct '12||Theodore J Cohen||1|
|Dendreon Will Sink If Provenge Fails (Apr '12)||Apr '12||Theodore Jerome C...||1|
|Seattle-based Dendreon to cut 500 jobs, slash s... (Sep '11)||Sep '11||HumanSpirit||1|
|Dendreon falls again after gain yesterday (Mar '11)||Mar '11||Rita||1|
Find what you want!
Search Dendreon Forum Now
Copyright © 2017 Topix LLC